In the world of cell and gene therapy, growth is both the goal and the challenge. Early-stage biotech companies begin with a handful of samples, managed in spreadsheets and tracked manually. But what happens when your promising therapy enters Phase II, scales to multi-site trials, and eventually moves toward commercialization? The complexity of managing biological and cell therapy samples grows exponentially, and manual processes simply can’t keep up. This is where a scalable sample inventory system, implemented step by step becomes essential for managing biological and cell therapy samples. In this use case deep dive, we explore how the right …